What is it used for?
VYLOY, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)‑negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin (CLDN) 18.2 positive as determined by an FDA-approved test .VYLOY, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)‑negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin (CLDN) 18.2 positive as determined by an FDA-approved test .
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- zolbetuximabzolbetuximab
- Form and strength
- INJECTION, POWDER, FOR SUSPENSION · 20 mg / 1 mLINJECTION, POWDER, FOR SUSPENSION · 20 mg / 1 mL
- Manufacturer / applicant
- ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.
For injection: 100 mg and 300 mg of zolbetuximab-clzb as a white to off-white lyophilized powder in a single-dose vial.For injection: 100 mg and 300 mg of zolbetuximab-clzb as a white to off-white lyophilized powder in a single-dose vial.
Safety and clinical review
- Hypersensitivity reactions, including anaphylaxis reactions, and infusion related reactionsHypersensitivity reactions, including anaphylaxis reactions, and infusion related reactions
- Severe Nausea and VomitingSevere Nausea and Vomiting
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is VYLOY used for?
VYLOY, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)‑negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin (CLDN) 18.2 positive as determined by an FDA-approved test .VYLOY, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)‑negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin (CLDN) 18.2 positive as determined by an FDA-approved test .
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of VYLOY should I ask about?
INJECTION, POWDER, FOR SUSPENSION · 20 mg / 1 mLINJECTION, POWDER, FOR SUSPENSION · 20 mg / 1 mL
Read the primary sourceWhat determines the price of VYLOY?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using VYLOY?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.